492 related articles for article (PubMed ID: 20458576)
1. Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis.
Macdonald HM; Nishiyama KK; Hanley DA; Boyd SK
Osteoporos Int; 2011 Jan; 22(1):357-62. PubMed ID: 20458576
[TBL] [Abstract][Full Text] [Related]
2. Characterizing microarchitectural changes at the distal radius and tibia in postmenopausal women using HR-pQCT.
Kawalilak CE; Johnston JD; Olszynski WP; Kontulainen SA
Osteoporos Int; 2014 Aug; 25(8):2057-66. PubMed ID: 24781379
[TBL] [Abstract][Full Text] [Related]
3. Postmenopausal women treated with combination parathyroid hormone (1-84) and ibandronate demonstrate different microstructural changes at the radius vs. tibia: the PTH and Ibandronate Combination Study (PICS).
Schafer AL; Burghardt AJ; Sellmeyer DE; Palermo L; Shoback DM; Majumdar S; Black DM
Osteoporos Int; 2013 Oct; 24(10):2591-601. PubMed ID: 23589163
[TBL] [Abstract][Full Text] [Related]
4. Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study).
Tsai JN; Uihlein AV; Burnett-Bowie SM; Neer RM; Derrico NP; Lee H; Bouxsein ML; Leder BZ
J Clin Endocrinol Metab; 2016 May; 101(5):2023-30. PubMed ID: 26964731
[TBL] [Abstract][Full Text] [Related]
5. Teriparatide increases strength of the peripheral skeleton in premenopausal women with idiopathic osteoporosis: a pilot HR-pQCT study.
Nishiyama KK; Cohen A; Young P; Wang J; Lappe JM; Guo XE; Dempster DW; Recker RR; Shane E
J Clin Endocrinol Metab; 2014 Jul; 99(7):2418-25. PubMed ID: 24684466
[TBL] [Abstract][Full Text] [Related]
6. Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT.
Hansen S; Hauge EM; Beck Jensen JE; Brixen K
J Bone Miner Res; 2013 Apr; 28(4):736-45. PubMed ID: 23044908
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT Study.
Tsai JN; Uihlein AV; Burnett-Bowie SA; Neer RM; Zhu Y; Derrico N; Lee H; Bouxsein ML; Leder BZ
J Bone Miner Res; 2015 Jan; 30(1):39-45. PubMed ID: 25043459
[TBL] [Abstract][Full Text] [Related]
8. Deterioration of trabecular plate-rod and cortical microarchitecture and reduced bone stiffness at distal radius and tibia in postmenopausal women with vertebral fractures.
Wang J; Stein EM; Zhou B; Nishiyama KK; Yu YE; Shane E; Guo XE
Bone; 2016 Jul; 88():39-46. PubMed ID: 27083398
[TBL] [Abstract][Full Text] [Related]
9. Effects of Denosumab and Teriparatide Transitions on Bone Microarchitecture and Estimated Strength: the DATA-Switch HR-pQCT study.
Tsai JN; Nishiyama KK; Lin D; Yuan A; Lee H; Bouxsein ML; Leder BZ
J Bone Miner Res; 2017 Oct; 32(10):2001-2009. PubMed ID: 28608571
[TBL] [Abstract][Full Text] [Related]
10. Effects of Combination Denosumab and High-Dose Teriparatide Administration on Bone Microarchitecture and Estimated Strength: The DATA-HD HR-pQCT Study.
Ramchand SK; David NL; Lee H; Bruce M; Bouxsein ML; Leder BZ; Tsai JN
J Bone Miner Res; 2021 Jan; 36(1):41-51. PubMed ID: 32790196
[TBL] [Abstract][Full Text] [Related]
11. Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Results of a 2-year study.
Rizzoli R; Chapurlat RD; Laroche JM; Krieg MA; Thomas T; Frieling I; Boutroy S; Laib A; Bock O; Felsenberg D
Osteoporos Int; 2012 Jan; 23(1):305-15. PubMed ID: 21909729
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Zoledronic Acid on Bone Microarchitecture and Strength after Denosumab and Teriparatide Administration: DATA-HD Study Extension.
Ramchand SK; David NL; Lee H; Bruce M; Bouxsein ML; Tsai JN; Leder BZ
J Bone Miner Res; 2023 Jan; 38(1):26-34. PubMed ID: 36333954
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of trabecular structure by HR-pQCT compared to gold standard μCT in the radius and tibia of patients with osteoporosis and long-term bisphosphonate therapy.
Krause M; Museyko O; Breer S; Wulff B; Duckstein C; Vettorazzi E; Glueer C; Püschel K; Engelke K; Amling M
Osteoporos Int; 2014 May; 25(5):1595-606. PubMed ID: 24566588
[TBL] [Abstract][Full Text] [Related]
14. Teriparatide treatment exerts differential effects on the central and peripheral skeleton: results from the MOAT study.
Paggiosi MA; Yang L; Blackwell D; Walsh JS; McCloskey E; Peel N; Eastell R
Osteoporos Int; 2018 Jun; 29(6):1367-1378. PubMed ID: 29520607
[TBL] [Abstract][Full Text] [Related]
15. Effects of odanacatib on the radius and tibia of postmenopausal women: improvements in bone geometry, microarchitecture, and estimated bone strength.
Cheung AM; Majumdar S; Brixen K; Chapurlat R; Fuerst T; Engelke K; Dardzinski B; Cabal A; Verbruggen N; Ather S; Rosenberg E; de Papp AE
J Bone Miner Res; 2014 Aug; 29(8):1786-94. PubMed ID: 24643905
[TBL] [Abstract][Full Text] [Related]
16. Teriparatide Followed by Denosumab in Premenopausal Idiopathic Osteoporosis: Bone Microstructure and Strength by HR-pQCT.
Agarwal S; Shiau S; Kamanda-Kosseh M; Bucovsky M; Kil N; Lappe JM; Stubby J; Recker RR; Guo XE; Shane E; Cohen A
J Bone Miner Res; 2023 Jan; 38(1):35-47. PubMed ID: 36335582
[TBL] [Abstract][Full Text] [Related]
17. Assessing the Effects of Teriparatide Treatment on Bone Mineral Density, Bone Microarchitecture, and Bone Strength.
Kleerekoper M; Greenspan SL; Lewiecki EM; Miller PD; Kendler DL; Maricic M; Keaveny TM; Kopperdahl DL; Ruff VA; Wan X; Janos B; Krohn K
J Bone Joint Surg Am; 2014 Jun; 96(11):e90. PubMed ID: 24897747
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study.
Senn C; Günther B; Popp AW; Perrelet R; Hans D; Lippuner K
Osteoporos Int; 2014 Jul; 25(7):1945-51. PubMed ID: 24760244
[TBL] [Abstract][Full Text] [Related]
19. Effect of oral monthly ibandronate on bone microarchitecture in women with osteopenia-a randomized placebo-controlled trial.
Chapurlat RD; Laroche M; Thomas T; Rouanet S; Delmas PD; de Vernejoul MC
Osteoporos Int; 2013 Jan; 24(1):311-20. PubMed ID: 22402673
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal HR-pQCT study of alendronate treatment in postmenopausal women with low bone density: Relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover.
Burghardt AJ; Kazakia GJ; Sode M; de Papp AE; Link TM; Majumdar S
J Bone Miner Res; 2010 Dec; 25(12):2558-71. PubMed ID: 20564242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
